- Main /
- Společnost /
- 591-alumis

IPO
ALMS.NASDAQ
Minulé
Alumis
Pharmaceuticals
Stránky společnostiTicker
ALMS.NASDAQ
Trh
us
Rok založení
2021
Datum IPO
6/13/2024
O společnosti
Alumis is dedicated to significantly enhancing patient lives by transitioning from broad immunosuppression to precise therapies. The name "Alumis" reflects this commitment, deriving from the French word "allumer" meaning to illuminate, and "immunis," the Latin term for the immune system.
Upisovatelé
Morgan Stanley, Leerink, Cantor, Guggenheim Securities